DOAJ Open Access 2024

A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma

J. Kaczmar K. Papadopoulos G. Ansstas A. Birnbaum J. Mehnert +13 lainnya

Lihat Sumber DOI

Topik & Kata Kunci

Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Penulis (18)

J. Kaczmar

K. Papadopoulos

G. Ansstas

A. Birnbaum

J. Mehnert

O. Hamid

B. Hughes

G. Rabinowits

A. Wei

M. Yushak

J. Mani

F. Fang

J. Wang

G. Kroog

M. Salvati

I. Lowy

M. Fury

N.J. Lakhani

Format Sitasi

APA MLA BibTeX

Kaczmar, J., Papadopoulos, K., Ansstas, G., Birnbaum, A., Mehnert, J., Hamid, O. et al. (2024). A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma. https://doi.org/10.1016/j.ejcskn.2024.100213

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1016/j.ejcskn.2024.100213

Informasi Jurnal

Tahun Terbit: 2024
Sumber Database: DOAJ
DOI: 10.1016/j.ejcskn.2024.100213
Akses: Open Access ✓